COVID-19 Webinar Series: What's Needed to Reopen Safely

Learn what’s needed on a national scale to safely reopen the U.S., including widespread antibody testing, vaccine development, and the mobilization of a new public health workforce. Infectious disease specialist and long-time public health officer Peter Kilmarx, MD, D’83, MED’90 shares his perspective on the latest information related to COVID-19 infection rates, antibody testing, vaccine development, and what’s needed from a scientific perspective to safely reopen the U.S. He also shares how the world’s largest biomedical research agency—the National Institutes of Health (NIH)—has channeled its extensive network and resources to address COVID-19. Within weeks, the agency began providing funding to academic labs—including some at Dartmouth—investigating nearly every aspect of the novel coronavirus.

Dr. Kilmarx leads the Fogarty International Center at the NIH and previously served in Centers for Disease Control and Prevention (CDC) for 21 years. He was named a Health Hero by CDC for his work in the fight against Ebola in 2014-15. He also served as CDC’s country director in Zimbabwe, managing implementation of the U.S. efforts to reduce HIV/AIDS, tuberculosis, and malaria.

[jenniferchen]

Your make this game better for your friends